Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era begins-Reference-Cited by-同舟云学术

Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era begins

Published:2015-12-23 Issue:3 Volume:57 Page:537-556
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Magarotto Valeria¹,Salvini Marco¹,Bonello Francesca¹,Bringhen Sara¹,Palumbo Antonio¹

Affiliation:

1. Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1102245

Reference75 articles.

1. Multiple Myeloma

2. Treatment Options for Relapsed and Refractory Multiple Myeloma

3. The development of potential antibody-based therapies for myeloma

4. Growth factors and antiapoptotic signaling pathways in multiple myeloma

5. Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD38 as an immunomodulator in cancer;Future Oncology;2020-12

2. Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development;Antibodies;2019-05-24

3. Novel anti-CD38 humanized mAb SG003 possessed enhanced cytotoxicity in lymphoma than Daratumumab via antibody-dependent cell-mediated cytotoxicity;BMC Biotechnology;2019-05-22

4. Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study;European Journal of Haematology;2018-04-25

5. Emerging immune targets for the treatment of multiple myeloma;Immunotherapy;2018-03-01